Scientific rationale for the possible inhaled corticosteroid intraclass difference in the risk of pneumonia in COPD.
about
Fluticasone propionate and increased risk of pneumonia in COPD: is it PAFR-dependent?Comparison of fluticasone propionate and budesonide on COPD macrophage and neutrophil functionCurrent appraisal of single inhaler triple therapy in COPDInhaled corticosteroids for chronic obstructive pulmonary disease: what is their role in therapy?
P2860
Scientific rationale for the possible inhaled corticosteroid intraclass difference in the risk of pneumonia in COPD.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Scientific rationale for the p ...... the risk of pneumonia in COPD.
@en
Scientific rationale for the p ...... the risk of pneumonia in COPD.
@nl
type
label
Scientific rationale for the p ...... the risk of pneumonia in COPD.
@en
Scientific rationale for the p ...... the risk of pneumonia in COPD.
@nl
prefLabel
Scientific rationale for the p ...... the risk of pneumonia in COPD.
@en
Scientific rationale for the p ...... the risk of pneumonia in COPD.
@nl
P2093
P2860
P921
P356
P1476
Scientific rationale for the p ...... the risk of pneumonia in COPD.
@en
P2093
Anna Miller-Larsson
Georgios Stratelis
Kjell Larsson
Tim W Harrison
P2860
P304
P356
10.2147/COPD.S143656
P407
P5008
P577
2017-10-19T00:00:00Z